Description:
The Company is an intensive outpatient programs (IOP) focused on addiction treatments. The Company offers day treatment, group therapy, one-on-one counseling, case management, and structured residential housing.

Key Aspects:
• The Company's revenue grew at a compound annual growth rate (CAGR) of 30.1% from 2022 through 2024.
• The Company achieved an adjusted EBITDA margin of 34.1% from 2022 through 2024.
• The Company accepts out-of-state patients.
• Residents and non-residents can utilize all services offered.
• IOP services are immediate and have no wait times.
• The Company's staff is composed of expert licensed therapists.
• The Company is licensed with several insurance companies.

Opportunities:
• Expand service offerings and hours of operation to reach more potential patients.
• Bring medical billing in-house to reduce expenses.
• Increase marketing to out-of-state clinical stabilization services (CSS) and hospitals to reach more potential patients.

Headquartered:
• Northeast, US

Real Estate:
• The Company operates from three day treatment facilities and seven structured residential houses. Two treatment facilities and seven homes are owned by an affiliated entity, which is expected to be included in the sale. The third treatment facility is leased from an unrelated third party.

Shareholder Objectives:
• The Company is fully owned by a single shareholder who is seeking an exit strategy. The owner is willing to remain with the Company for a predetermined period to facilitate a smooth transition to new ownership.